Jeremy Bray, 29, lives with Spinal Muscular Atrophy, a neurodegenerative disorder that causes the loss of motor neurons and ...

Manitoba Premier Wab Kinew says the province is reversing its decision and will ensure a 30-year-old battling a degenerative ...

The province made a one-year commitment to pay for Bray’s treatment, which is estimated to cost $300,000 annually. Manitoba ...

Tears gathered in Jeremy Bray’s eyes as he absorbed the news that his pleas for Manitoba’s government to cover his ...

A Rivers man born with a rare motor neuron disease causing his muscles to slowly weaken worries his family won’t be able to ...

The Food and Drug Administration is adding a new warning to a gene therapy linked to two patient deaths earlier this year.

The specific tool that saved my day is called Home Up. Even after you install Good Lock, you have to download this specific ...

The United States on Friday said it would add its most serious warning label to a gene therapy treatment for a debilitating ...

Novartis secured approval for its drug to treat certain patients diagnosed with spinal muscular atrophy from the Food and Drug Administration.

The U.S. Food and Drug Administration has approved Novartis' gene therapy for patients with a rare muscle disorder, the drugmaker said on Monday.

U.S. Food and Drug Administration has approved Novartis' gene therapy for a type of rare muscle disorder, the drugmaker said ...